Notice2023-28574

National Institute on Drug Abuse; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 27, 2023

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 247 (Wednesday, December 27, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 247 (Wednesday, December 27, 2023)]
[Notices]
[Page 89463]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-28574]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; JCOIN Methodology Center (MAARC) and JCOIN 
Coordination Center (CTC).
    Date: February 16, 2024.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, (Virtual 
Meeting).
    Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer, 
Scientific Review Branch, Division of Extramural Research, National 
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC, 
6021 Bethesda, MD 20892, (301) 594-9460, <a href="/cdn-cgi/l/email-protection#f5a69a8c9a809bdb969d9ab59b9c9ddb929a83"><span class="__cf_email__" data-cfemail="75261a0c1a001b5b161d1a351b1c1d5b121a03">[email&#160;protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA Research Center of Excellence Grant Program and 
NIDA Core ``Center of Excellence'' Grant Program.
    Date: February 26-27, 2024.
    Time: 11:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, (Virtual 
Meeting).
    Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer, 
Scientific Review Branch, Division of Extramural Research, National 
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC, 
6021 Bethesda, MD 20892, (301) 594-9460, <a href="/cdn-cgi/l/email-protection#ffac9086908a91d19c9790bf919697d1989089"><span class="__cf_email__" data-cfemail="d88bb7a1b7adb6f6bbb0b798b6b1b0f6bfb7ae">[email&#160;protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Research at Minority Serving Institutions on 
Neurocognitive Mechanisms Underlying the Impact of Structural Racism 
on the Substance Use Trajectory.
    Date: March 14, 2024.
    Time: 1:30 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, (Virtual 
Meeting).
    Contact Person: Shareen Amina Iqbal, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, 
MSC, 6021 Bethesda, MD 20892, (301) 443-4577, <a href="/cdn-cgi/l/email-protection#6a19020b180f0f0444031b080b062a040302440d051c"><span class="__cf_email__" data-cfemail="36455e5744535358185f4754575a76585f5e18515940">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: December 21, 2023.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-28574 Filed 12-26-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on December 27, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.